These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20037838)

  • 21. A New Recalibrated Four-Category Child-Pugh Score Performs Better than the Original Child-Pugh and MELD Scores in Predicting In-Hospital Mortality in Decompensated Alcoholic Cirrhotic Patients with Acute Variceal Bleeding: a Real-World Cohort Analysis.
    Krige J; Spence RT; Jonas E; Hoogerboord M; Ellsmere J
    World J Surg; 2020 Jan; 44(1):241-246. PubMed ID: 31583458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-dimensional conformal radiotherapy for locally advanced hepatocellular carcinoma with portal vein tumour thrombosis: evaluating effectiveness of the model for end-stage liver disease (MELD) score compared with the Child-Pugh classification.
    Okazaki E; Yamamoto A; Nishida N; Hamuro M; Ogino R; Hosono M; Shimatani Y; Tsutsumi S; Hamamoto S; Sohgawa E; Jogo A; Miki Y
    Br J Radiol; 2016 Jul; 89(1063):20150945. PubMed ID: 27164029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.
    Marroni CP; de Mello Brandão AB; Hennigen AW; Marroni C; Zanotelli ML; Cantisani G; Fuchs SC;
    Clin Transplant; 2012; 26(4):E395-401. PubMed ID: 22882694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MELD scores and Child-Pugh classifications predict the outcomes of ERCP in cirrhotic patients with choledocholithiasis: a retrospective cohort study.
    Zhang J; Ye L; Zhang J; Lin M; He S; Mao X; Zhou X; Zhi F
    Medicine (Baltimore); 2015 Jan; 94(3):e433. PubMed ID: 25621696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting short-term survival after liver transplantation on eight score systems: a national report from China Liver Transplant Registry.
    Ling Q; Dai H; Zhuang R; Shen T; Wang W; Xu X; Zheng S
    Sci Rep; 2017 Feb; 7():42253. PubMed ID: 28198820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic evaluation of patients undergoing living-donor liver transplant by APACHE II and MELD scores.
    Zhang ZY; Chen R; Zhou ZQ; Peng CH; Zhou GW
    Exp Clin Transplant; 2015 Feb; 13(1):41-5. PubMed ID: 24779711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
    Lv XH; Liu HB; Wang Y; Wang BY; Song M; Sun MJ
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-Center Experience on Liver Transplantation for Model for End-Stage Liver Disease Score 40 Patients.
    Sotiropoulos GC; Vernadakis S; Paul A; Hoyer DP; Saner FH; Gallinat A
    Dig Dis Sci; 2016 Nov; 61(11):3346-3353. PubMed ID: 27538409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased Level of Interleukin 6 Associates With Increased 90-Day and 1-Year Mortality in Patients With End-Stage Liver Disease.
    Remmler J; Schneider C; Treuner-Kaueroff T; Bartels M; Seehofer D; Scholz M; Berg T; Kaiser T
    Clin Gastroenterol Hepatol; 2018 May; 16(5):730-737. PubMed ID: 28919544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High MELD score does not adversely affect outcome of living donor liver transplantation: Experience in 1000 recipients.
    Yadav SK; Saraf N; Saigal S; Choudhary NS; Goja S; Rastogi A; Bhangui P; Soin AS
    Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28497523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pretransplant model for end stage liver disease score predicts posttransplant incidence of fungal infections after liver transplantation.
    Lichtenstern C; Hochreiter M; Zehnter VD; Brenner T; Hofer S; Mieth M; Büchler MW; Martin E; Weigand MA; Schemmer P; Busch CJ
    Mycoses; 2013 May; 56(3):350-7. PubMed ID: 23346877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement in the Outcomes of MELD ≥ 40 Liver Transplantation: An Analysis of 207 Consecutive Transplants in a Highly Competitive DSA.
    Nekrasov V; Matsuoka L; Kaur N; Pita A; Whang G; Cao S; Groshen S; Alexopoulos S
    Transplantation; 2017 Oct; 101(10):2360-2367. PubMed ID: 28319564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of different scoring systems in predicting short-term mortality after liver transplantation.
    Elsayed FG; Sholkamy AA; Elshazli M; Elshafie M; Naguib M
    Transplant Proc; 2015 May; 47(4):1207-10. PubMed ID: 26036555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The application of MELD score in patients submitted to liver transplantation: a retrospective analysis of survival and the predictive factors in the short and long term].
    Boin Ide F; Leonardi MI; Udo EY; Sevá-Pereira T; Stucchi RS; Leonardi LS
    Arq Gastroenterol; 2008; 45(4):275-83. PubMed ID: 19148354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Living donor liver transplant versus cadaveric liver transplant survival in relation to model for end-stage liver disease score.
    Al Sebayel M; Abaalkhail F; Hashim A; Al Bahili H; Alabbad S; Shoukdy M; Elsiesy H
    Transplant Proc; 2015 May; 47(4):1211-3. PubMed ID: 26036556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of MELD allocation policy on survival outcomes after liver transplantation: a single-center study in northeast Brazil.
    Batista TP; Sabat BD; Melo PS; Miranda LE; Fonseca-Neto OC; Amorim AG; Lacerda CM
    Clinics (Sao Paulo); 2011; 66(1):57-64. PubMed ID: 21437437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis.
    Cheng XP; Zhao J; Chen Y; Meng FK; Xu B; Yu HW; Meng QH; Liu YM; Zhang SB; Meng S; Zhang JY; Zhang JY; Duan ZP; Zheng SJ
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):444-8. PubMed ID: 26649802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postoperative resource utilization and survival among liver transplant recipients with Model for End-stage Liver Disease score ≥ 40: A retrospective cohort study.
    Cardoso FS; Karvellas CJ; Kneteman NM; Meeberg G; Fidalgo P; Bagshaw SM
    Can J Gastroenterol Hepatol; 2015 May; 29(4):185-91. PubMed ID: 25965438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting Mortality Across a Broad Spectrum of Liver Disease-An Assessment of Model for End-Stage Liver Disease (MELD), Child-Turcotte-Pugh (CTP), and Creatinine-Modified CTP Scores.
    Chawla YK; Kashinath RC; Duseja A; Dhiman RK
    J Clin Exp Hepatol; 2011 Dec; 1(3):161-8. PubMed ID: 25755381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MELD vs Child-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis.
    Papatheodoridis GV; Cholongitas E; Dimitriadou E; Touloumi G; Sevastianos V; Archimandritis AJ
    World J Gastroenterol; 2005 May; 11(20):3099-104. PubMed ID: 15918197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.